● Director of the Translational Science Team, lead 6 direct reports located in Boston, MA.● Lead and managed the Translational Science Team, including overall biomarker clinical operations, infrastructure, communications, and planning and execution of activities for clinical trial development and correlative cancer research● Set priorities, timelines, and drove the overall deliverables for the Translational Science Team. Served as bridge between clinical development, operations, stats, labs, sites, CROs, vendors, and the specimen biorepository.● Oversaw and interacted with the ECOG-ACRIN biospecimen biorepository located at MD Anderson in Houston, TX. ● Performed biomarker research and presented at bi-annual conferences and meetings. Tracked biomarker research in trials. ● Developed protocols across multiple cancer disease areas, provided scientific input on biomarker strategy● Created, managed, and reviewed budgets, contracts, SOPs, and reports.● Interacted regularly with the National Cancer Institute (NCI), and other government, industry, and academic institutions. ● Lead and developed appropriate informatics platforms, including NCTN Navigator and LIMS for the National Cancer Institute.● Participated in Group Banking Subcommittees, and manages biospecimen banking activities, including consolidation efforts● Participated in working group and review committee meetings, and provided scientific and operational guidance.● Authored and submits various grants (U10, U24, BIQSFP) and progress reports● Participated in publication activities● Traveled to the bi-annual Group Meeting, and other scientific conferences as an ECOG-ACRIN representative.

● Performed research in the field of oncology, including model development and methodology, data acquisition, meta-analysis, and discovery & development efforts related to cancer research and therapeutics. ● Oversaw scientific aspects of a small software programming company as lead scientist. ● Organized and presented capabilities of LABCAT software; a propriety data acquisition, analysis, and reporting software suite for in-life oncology research, necropsy, toxicology, pathology, pharmacology, and basic research. ● Interacted with a team of programmers to develop acquisition modules and macros for scientific research. ● Communicated with current and prospective clients, including training and troubleshooting. ● Tested and troubleshooted medical devices for data acquisition.

● Member of the GSK Antibacterial Biothreat team focusing on discovery and development of therapeutics to treat multiple drug-resistant bacterial infections, including anthrax, plague, spotted fever, and other fatal diseases contributed to bioterrorism.● Oversaw study management for in-house and outsourced animal biothreat studies, including study design, proposals, protocol development, budgeting, scheduling, regulatory, and reporting.● Participated in animal model study design, including pathogen natural history, PK/PD, POC, single and multi-dose efficacy, tolerability, and survival studies. ● Interacted with government agencies, including Defense Threat Reduction Agency (DTRA), and the Biomedical Advanced Research and Development Authority (BARDA) to progress studies through drug development.

● Identified and collaborated with CRO's and academic laboratories for appropriate preclinical assays for Drug Discovery projects.● Acquired and negotiated quotes, and managed budgets for assigned projects reported directly to the Executive VP of Discovery.● Collaborated with and managed contacts, oversaw shipping, tracked study progress, and reported on a variety of studies including in vitro toxicology screens, receptor and channel profiling, in vivo toxicology, PK, safety studies, cell-based functional assays, general laboratory maintenance, and other relevant projects.

Department of Biology; Drug Discovery & DevelopmentInnovative Respiratory MedicinesScientist III - Nov 2011 - May 2014Scientist I - Feb 2008 - Nov 2011● Communicated and collaborated with colleagues, contributing to the development of an efficient, integrated, high-performance Drug Discovery group in the field of respiratory therapeutics.● Researched and developed appropriate in vivo models to evaluate whole-body and molecular physiology of ventilatory control disease models, effects of compounds on experimental variables, and site of action for the impact on ventilatory control, cardiorespiratory systems, nociception, behavior, and safety profiles of novel compounds.● Participated in the identification and installation of several drug discovery programs, including two programs that led to the founding of 2 clinical drug candidates, one of which was tested in phase I/II clinical trials in 2011 and 2012.● Ran and reported on appropriate drug discovery assays relevant to ventilatory control including plethysmography, telemetry, pulse oximetry, spirometry, arterial blood gases, tail-flick, rotarod, behavioral assays, audio recordings, blood sampling, tissue harvest, and PK/PD studies● Performed small mammal survival surgery and post-operative care, including telemetry surgery (Millar, Inc.), transections, and cannulations.● Authored scientific reports, SOPs, general and IACUC protocols, IND/IMPD reports, manuscripts, and scientific posters.● Attended professional seminars and lectures, and served as an ambassador for the company’s university affiliations at The University of the Sciences in Philadelphia, the University of Virginia, East Carolina University, and the University of Pennsylvania.● Contributed to the overall running of the Drug Discovery and Development group, including operational aspects as a member on various committees.● Trained as a Project Manager and Clinical Research Associate.

Cardiovascular Centre of Excellence for Drug Discovery● Participated in a variety of experiments involving cardiovascular and urogenital responses to GSK compound through the use of telemetry blood pressure and biopotential implants in various strains of rodents.● Performed phenotyping and metabolic experiments in knock-out mouse strains. Oversaw and performed dosing and sample processing for PK/PD analysis. ● Actively participated in data analysis and interpretation for project meetings. ● Authored protocols, ran experiments, assisted with surgeries, and performed tissue harvesting.

Department of Molecular Ophthalmology● Oversaw and performed a variety of experiments involving molecular identification, quantification, and purification of human and rodent DNA/RNA samples, snps, and other PCR-based assays including sequencing and genotyping.● Utilized appropriate bioinformatics techniques including molecular databases and nucleotide/protein alignment tools.● Oversaw all DNA sequencing projects for the department, maintained a genomic DNA library and knock out mouse colony.● Performed tissue culturing, cryosectioning, in situ hybridization and immunoblotting

Department of Safety Assessment● Participated in the design and analysis of preclinical safety assessment procedures and monitoring of respiratory and cardiovascular parameters in non-human primates, canines, and rodents using telemetry, plethysmography, and other safety and toxicology assays.● Performed laboratory techniques including dosing, bleeds, tissue harvest, PK/PD, and processing for in vivo studies.

Department of Entomology● Assisted in research on sex pheromone-mediated behavior and peripheral olfactory events in various moth species and other insects.● Oversaw all insect rearing procedures and general laboratory maintenance.

Department of Biochemistry● Performed a variety of laboratory procedures including electrophoresis, and plating bacteria and cells.● Prepared solutions and culture plates for cell growth.

● Organized, managed, and instructed a variety of environmental education programs for the general public.● Maintained and rehabilitated many species of wild birds, reptiles, and mammals.